Dechra cites encouraging start to new year

This post was originally published on this site

Management at Dechra Pharmaceuticals (DPH) cited a “resilient” full-year performance, notwithstanding Covid-19 disruption in recent months. That sentiment was borne out by the veterinary healthcare group’s preliminary figures, with operating profits …

Click here to read full article